Cargando…
Butyrate Protects against Clostridium difficile Infection by Regulating Bile Acid Metabolism
Clostridium difficile infection (CDI) is caused by a prevalent nosocomial enteric pathogen, leading to high morbidity and mortality. CDI recurrence after antibiotic treatment is high; therefore, it is necessary to develop novel therapeutics against this enteric pathogen. Butyrate is used to treat ma...
Autores principales: | Wang, Siqi, Xiang, Leyang, li, Fang, Deng, Wenlin, lv, Pinjing, Chen, Ye |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10434071/ https://www.ncbi.nlm.nih.gov/pubmed/37350595 http://dx.doi.org/10.1128/spectrum.04479-22 |
Ejemplares similares
-
Metformin Exerts Anti-inflammatory and Mucus Barrier Protective Effects by Enriching Akkermansia muciniphila in Mice With Ulcerative Colitis
por: Ke, Haoran, et al.
Publicado: (2021) -
Bile acid-independent protection against Clostridioides difficile infection
por: Aguirre, Andrea Martinez, et al.
Publicado: (2021) -
Metabolism of Bile Salts in Mice Influences Spore Germination in Clostridium difficile
por: Giel, Jennifer L., et al.
Publicado: (2010) -
Precision microbiome restoration of bile acid-mediated resistance to Clostridium difficile
por: Buffie, Charlie G., et al.
Publicado: (2014) -
Evaluation of the Risk of Clostridium difficile Infection Using a Serum Bile Acid Profile
por: Monma, Tadakuni, et al.
Publicado: (2022)